John Aballi Exagen Inc. (XGN) insider trading activity

XGN Quotes by TradingView

John Aballi is President and CEO of EXAGEN INC.. Currently has a direct ownership of 689,799 shares of XGN, which is worth approximately $3.25 Million. The most recent transaction as insider was on Nov 14, 2024, when has been sold 24,305 shares (Common Stock) at a price of $2.81 per share, resulting in proceeds of $68,297. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 690K
14.82% 3M change
65.82% 12M change
Total Value Held $3.25 Million

JOHN ABALLI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 14 2024
BUY
Open market or private purchase
$68,297 $2.81 p/Share
24,305 Added 3.4%
689,799 Common Stock
Feb 29 2024
BUY
Grant, award, or other acquisition
$18,725 $1.91 p/Share
9,804 Added 1.61%
600,788 Common Stock
Feb 20 2024
BUY
Grant, award, or other acquisition
-
175,000 Added 22.85%
590,984 Common Stock
Oct 17 2023
SELL
Open market or private sale
$59,183 $1.75 p/Share
33,819 Reduced 7.52%
415,984 Common Stock
Aug 31 2023
BUY
Grant, award, or other acquisition
$20,978 $2.14 p/Share
9,803 Added 2.13%
449,803 Common Stock
Dec 08 2022
BUY
Open market or private purchase
$241,200 $2.68 p/Share
90,000 Added 16.98%
440,000 Common Stock
Oct 16 2022
BUY
Grant, award, or other acquisition
-
350,000 Added 50.0%
350,000 Restricted Stock Units
JA

John Aballi

President and CEO
Vista, CA

Track Institutional and Insider Activities on XGN

Follow EXAGEN INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XGN shares.

Notify only if

Insider Trading

Get notified when an Exagen Inc. insider buys or sells XGN shares.

Notify only if

News

Receive news related to EXAGEN INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XGN